메뉴 건너뛰기




Volumn 24, Issue 5, 2003, Pages 216-218

Protein transduction technology offers novel therapeutic approach for brain ischemia

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME C; POLYARGININE; PROTEIN; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL X; PROTEIN BCL XL; PROTEIN TAT FNK; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

EID: 0038325747     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-6147(03)00074-9     Document Type: Short Survey
Times cited : (46)

References (10)
  • 1
    • 0033199996 scopus 로고    scopus 로고
    • Pathobiology of ischaemic stroke: An integrated view
    • Dirnagl U., et al. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci. 22:1999;391-397.
    • (1999) Trends Neurosci. , vol.22 , pp. 391-397
    • Dirnagl, U.1
  • 2
    • 0036141160 scopus 로고    scopus 로고
    • Neuroprotection is unlikely to be effective in humans using current trial designs
    • Grotta J. Neuroprotection is unlikely to be effective in humans using current trial designs. Stroke. 33:2002;306-307.
    • (2002) Stroke , vol.33 , pp. 306-307
    • Grotta, J.1
  • 3
    • 0035122040 scopus 로고    scopus 로고
    • Programmed cell death in cerebral ischemia
    • Graham S.H., Chen J. Programmed cell death in cerebral ischemia. J. Cereb. Blood Flow Metab. 21:2001;99-109.
    • (2001) J. Cereb. Blood Flow Metab. , vol.21 , pp. 99-109
    • Graham, S.H.1    Chen, J.2
  • 4
    • 0035146929 scopus 로고    scopus 로고
    • Life-or-death decisions by the Bcl-2 protein family
    • Adams J.M., Cory S. Life-or-death decisions by the Bcl-2 protein family. Trends Biochem. Sci. 26:2001;61-66.
    • (2001) Trends Biochem. Sci. , vol.26 , pp. 61-66
    • Adams, J.M.1    Cory, S.2
  • 5
    • 0037168589 scopus 로고    scopus 로고
    • Protection against ischemic brain injury by protein therapeutics
    • Asoh S., et al. Protection against ischemic brain injury by protein therapeutics. Proc. Natl. Acad. Sci. U. S. A. 99:2002;17107-17112.
    • (2002) Proc. Natl. Acad. Sci. U. S. A. , vol.99 , pp. 17107-17112
    • Asoh, S.1
  • 6
    • 0036829818 scopus 로고    scopus 로고
    • Intravenous TAT-Bcl-Xl is protective after middle cerebral artery occlusion in mice
    • Kilic E., et al. Intravenous TAT-Bcl-Xl is protective after middle cerebral artery occlusion in mice. Ann. Neurol. 52:2002;617-622.
    • (2002) Ann. Neurol. , vol.52 , pp. 617-622
    • Kilic, E.1
  • 7
    • 0036663014 scopus 로고    scopus 로고
    • In vivo delivery of a Bcl-xL fusion protein containing the TAT protein transduction domain protects against ischemic brain injury and neuronal apoptosis
    • Cao G., et al. In vivo delivery of a Bcl-xL fusion protein containing the TAT protein transduction domain protects against ischemic brain injury and neuronal apoptosis. J. Neurosci. 22:2002;5423-5431.
    • (2002) J. Neurosci. , vol.22 , pp. 5423-5431
    • Cao, G.1
  • 8
    • 0036395238 scopus 로고    scopus 로고
    • Inhibition of neuronal apoptosis in vitro and in vivo using TAT-mediated protein transduction
    • Dietz G.P., et al. Inhibition of neuronal apoptosis in vitro and in vivo using TAT-mediated protein transduction. Mol. Cell. Neurosci. 21:2002;29-37.
    • (2002) Mol. Cell. Neurosci. , vol.21 , pp. 29-37
    • Dietz, G.P.1
  • 10
    • 0033520487 scopus 로고    scopus 로고
    • In vivo protein transduction: Delivery of a biologically active protein into the mouse
    • Schwarze S.R., et al. In vivo protein transduction: delivery of a biologically active protein into the mouse. Science. (285):1999;1569-1572.
    • (1999) Science , Issue.285 , pp. 1569-1572
    • Schwarze, S.R.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.